Patent: 7,658,768
✉ Email this page to a colleague
Summary for Patent: 7,658,768
| Title: | Bone graft substitute composition |
| Abstract: | Bone graft substitute compositions and methods of making the compositions are disclosed. In some embodiments, a method of making a composition includes contacting a mixing solution with a first mixture having calcium sulfate hemihydrate and a plasticizing material to form a second mixture; waiting a predetermined period of time after forming said second mixture; and then contacting demineralized bone with the second mixture to form the composition. A composition can be formed from a kit including a first mixture having calcium sulfate hemihydrate and a plasticizing substance, a second mixture having demineralized bone, and a mixing solution. The first and second mixtures and the mixing solution are unblended. |
| Inventor(s): | Miller; Leasa C. (Covington, TN), Richelsoph; Kelly Coupe (Memphis, TN), Moseley; Jon P. (Arlington, TN) |
| Assignee: | Wright Medical Technology, Inc. (Arlington, TX) |
| Application Number: | 11/872,564 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,658,768
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp. | ZOSTAVAX | zoster vaccine live | For Injection | 125123 | 05/25/2006 | ⤷ Try a Trial | 2022-06-24 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
